Pinnacle Medicines
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $89M
Investors
- 8
About Pinnacle Medicines
Founded in 2024 in Doylestown, US, Pinnacle Medicines, Inc. develops oral peptide therapeutics targeting chronic diseases.Pinnacle Medicines specializes in the development of innovative oral peptide therapeutics designed to address chronic diseases with unmet medical needs. The company's core offerings leverage advancements in peptide science to create oral therapies that aim to deliver antibody-like efficacy in a convenient pill format, enhancing patient adherence and quality of life. These products are engineered to provide precise biological targeting, thereby optimizing therapeutic outcomes for patients. Pinnacle Medicines focuses on markets across North America and Asia, aiming to serve healthcare providers and patients managing chronic conditions.Pinnacle Medicines generates revenue through strategic partnerships and direct sales of its oral peptide therapeutics to healthcare providers and specialty pharmacies. The company structures its transactions primarily on a B2B model, collaborating with pharmaceutical distributors and healthcare institutions to facilitate product availability. Revenue streams are bolstered by agreements that may include milestone payments and royalties linked to the successful commercialization of its product pipeline. Pinnacle Medicines' flagship offerings are aimed at delivering effective treatment alternatives for patients, with each product being positioned to cater to specific therapeutic areas within the chronic disease spectrum.Pinnacle Medicines, Inc. The company is targeting expansion into new markets across North America and Asia by 2025, aiming to increase accessibility for healthcare providers and patients.
Who invested in Pinnacle Medicines
8 investors across 2 rounds
See all investors in Pinnacle Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pinnacle Medicines
Who invested in Pinnacle Medicines?
Pinnacle Medicines has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pinnacle Medicines raised?
Pinnacle Medicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pinnacle Medicines last raise money?
Pinnacle Medicines's most recent round on record is a Series B, in Mar 2026.
What does Pinnacle Medicines do?
Founded in 2024 in Doylestown, US, Pinnacle Medicines, Inc.
Where is Pinnacle Medicines headquartered?
Pinnacle Medicines is headquartered in Doylestown, US.
Which VCs invest in companies like Pinnacle Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pinnacle Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pinnacle Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.